Credit Suisse Starts Fulgent Genetics (FLGT) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
Piper Jaffray Starts Fulgent Genetics (FLGT) at Overweight
October 24, 2016 7:33 AM EDTPiper Jaffray initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with an Overweight rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Fulgent Genetics click here. For more ratings news on Fulgent Genetics click here.
Shares of Fulgent Genetics closed at $8.88 yesterday.
... MoreBTIG Starts Fulgent Genetics (FLGT) at Buy
October 24, 2016 7:32 AM EDTBTIG initiated coverage on Fulgent Genetics (NASDAQ: FLGT) with a Buy rating and a price target of $15.
Analyst Karen Koski said, "While the genetic testing market is not without challenges and competition is formidable, we believe Fulgents proprietary technology platform drives multiple sustainable... More
